Prognostic impact of hyponatraemia and hypernatraemia at admission and discharge in heart failure patients with preserved, mid-range and reduced ejection fraction

被引:11
作者
Vicent, Lourdes [1 ,2 ]
Alvarez-Garcia, Jesus [7 ]
Gonzalez-Juanatey, Jose Ramon [8 ]
Rivera, Miguel [12 ]
Segovia, Javier [3 ]
Worner, Fernando [9 ]
Bover, Ramon [4 ]
Pascual-Figal, Domingo [10 ]
Vazquez, Rafael [11 ]
Cinca, Juan [7 ]
Fernandez-Aviles, Francisco [2 ,5 ]
Martinez-Selles, Manuel [2 ,5 ,6 ]
机构
[1] Hosp Univ 12 Octubre, Cardiol Dept, Madrid, Spain
[2] Hosp Gen Univ Gregorio Maranon, CIBERCV, Cardiol Dept, Madrid, Spain
[3] Hosp Univ Puerta Hierro Majadahonda, CIBERCV, Cardiol Dept, Madrid, Spain
[4] Hosp Clin San Carlos, Cardiol Dept, Madrid, Spain
[5] Univ Complutense, Madrid, Spain
[6] Univ Europea, Madrid, Spain
[7] Hosp Santa Creu & Sant Pau, Cardiol Dept, CIBERCV, Barcelona, Spain
[8] Complexo Hosp Univ Santiago Compostela, Cardiol & Coronary Care Unit Dept, CIBERCV, La Coruna, Spain
[9] Hosp Arnau Vilanova, IRBLLEIDA, Cardiol Dept, Lleida, Spain
[10] Hosp Clin Univ Virgen Arrixaca, Cardiol Dept, El Palmar, Spain
[11] Puerta Mar Univ Hosp, Cardiol Dept, Cadiz, Spain
[12] Univ Hosp La Fe, Cardiol Dept, Valencia, Spain
关键词
hyponatraemia; hypernatraemia; heart failure; sodium; mortality; readmissions; SERUM SODIUM CONCENTRATION; MORTALITY; PATHOPHYSIOLOGY; INHIBITORS;
D O I
10.1111/imj.14836
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Hyponatraemia is common in patients with acute heart failure (HF). Aims: To determine the impact of sodium disturbances on mortality and readmissions in HF with reduced left ventricular ejection fraction (HFrEF), preserved ejection fraction (HFpEF) and mid-range ejection fraction (HFmrEF). Methods This study was a prospective multicentre consecutive registry in 20 hospitals, including patients admitted due to acute HF in cardiology departments. Sodium <135 mmol/L was considered hyponatraemia, >145 mmol/L hypernatraemia and 135-145 mmol/L normal. Results A total of 1309 patients was included. Mean age was 72.0 +/- 11.9 years, and 810 (61.9%) were male. Mean serum sodium level was 138.6 +/- 4.7 mmol/L at hospital admission and 138.1 +/- 4.1 mmol/L at discharge. The evolution of sodium levels was: normal-at-admission/normal-at-discharge 941 (71.9%), abnormal-at-admission/normal-at-discharge 127 (9.7%), normal-at-admission/abnormal-at-discharge 155 (11.8%) and abnormal-at-admission/abnormal-at-discharge 86 (6.6%). Hyponatraemia at discharge was more common in HFrEF (109 (20.7%)) than in HFpEF (79 (13.9%)) and HFmrEF (27 (12%)), P = 0.003. The prevalence of hypernatraemia at discharge was similar in the three groups: HFrEF (10 (1.9%)), HFpEF (12 (2.1%)) and HFmrEF (4 (1.9%)), P = 0.96. In multivariate analysis, abnormal sodium concentrations at hospital admission (hazard ratio (HR) 1.42, 95% confidence interval (CI) 1.15-1.76, P = 0.001) and discharge (HR 1.33, 95% CI 1.08-1.64, P = 0.007) were both independently associated with increased mortality and readmissions at 12 months. Conclusions Hyponatraemia and hypernatraemia at admission and discharge predict a poor outcome in patients with acute HF regardless of left ventricular ejection fraction. Hyponatraemia at discharge is more frequent in HFrEF than in the other groups.
引用
收藏
页码:930 / 938
页数:9
相关论文
共 30 条
[1]   Prevalence and prognostic significance of hyponatraemia in outpatients with chronic heart failure [J].
Balling, Louise ;
Schou, Morten ;
Videbaek, Lars ;
Hildebrandt, Per ;
Wiggers, Henrik ;
Gustafsson, Finn .
EUROPEAN JOURNAL OF HEART FAILURE, 2011, 13 (09) :968-973
[2]   Prognostic Significance of Hyponatremia Among Ambulatory Patients With Heart Failure and Preserved and Reduced Ejection Fractions [J].
Bavishi, Chirag ;
Ather, Sameer ;
Bambhroliya, Arvind ;
Jneid, Hani ;
Virani, Salim S. ;
Bozkurt, Biykem ;
Deswal, Anita .
AMERICAN JOURNAL OF CARDIOLOGY, 2014, 113 (11) :1834-1838
[3]   Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment [J].
Borlaug, Barry A. ;
Paulus, Walter J. .
EUROPEAN HEART JOURNAL, 2011, 32 (06) :670-+
[4]   Hospital Management of Hyponatremia in Patients with Heart Failure: Final Report from the RN Registry [J].
Chiong, Jun R. ;
Hauptman, Paul J. ;
Dunlap, Mark E. ;
Chiodo, Joseph A., III ;
Chase, Sandra L. .
JOURNAL OF CARDIAC FAILURE, 2014, 20 (08) :S62-S63
[5]   Dysnatraemia in heart failure [J].
Deubner, Nikolas ;
Berliner, Dominik ;
Frey, Anna ;
Gueder, Guelmisal ;
Brenner, Susanne ;
Fenske, Wiebke ;
Allolio, Bruno ;
Ertl, Georg ;
Angermann, Christiane E. ;
Stoerk, Stefan .
EUROPEAN JOURNAL OF HEART FAILURE, 2012, 14 (10) :1147-1154
[6]   Current Management of Hyponatremia in Acute Heart Failure: A Report From the Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia (HN Registry) [J].
Dunlap, Mark E. ;
Hauptman, Paul J. ;
Amin, Alpesh N. ;
Chase, Sandra L. ;
Chiodo, Joseph A., III ;
Chiong, Jun R. ;
Dasta, Joseph F. .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (08)
[7]   Efficacy of ACE inhibitors in chronic heart failure with preserved ejection fraction - A meta analysis of 7 prospective clinical studies [J].
Fu, Mingqiang ;
Zhou, Jingmin ;
Sun, Aijun ;
Zhang, Shuning ;
Zhang, Chunyu ;
Zou, Yunzeng ;
Fu, Michael ;
Ge, Junbo .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 155 (01) :33-38
[8]   Mid-range Ejection Fraction Does Not Permit Risk Stratification Among Patients Hospitalized for Heart Failure [J].
Gomez-Otero, Ines ;
Ferrero-Gregori, Andreu ;
Varela Roman, Alfonso ;
Seijas Amigo, Jose ;
Pascual-Figal, Domingo A. ;
Delgado Jimenez, Juan ;
Alvarez-Garcia, Jesus ;
Fernandez-Aviles, Francisco ;
Worner Diz, Fernando ;
Alonso-Pulpon, Luis ;
Cinca, Juan ;
Ramon Gonzalez-Juanatey, Jose .
REVISTA ESPANOLA DE CARDIOLOGIA, 2017, 70 (05) :338-346
[9]   Heart Failure With Mid-Range (Borderline) Ejection Fraction Clinical Implications and Future Directions [J].
Hsu, Jeffrey J. ;
Ziaeian, Boback ;
Fonarow, Gregg C. .
JACC-HEART FAILURE, 2017, 5 (11) :764-771
[10]   Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure -: Results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study [J].
Klein, L ;
O'Connor, CM ;
Leimberger, JD ;
Gattis-Stough, W ;
Piña, IL ;
Felker, M ;
Adams, KF ;
Califf, RM ;
Gheorghiade, M .
CIRCULATION, 2005, 111 (19) :2454-2460